Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001564590-20-043577
Filing Date
2020-09-15
Accepted
2020-09-15 15:14:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 nvus-424b3.htm 424B3 4880
  Complete submission text file 0001564590-20-043577.txt   5968
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-237379 | Film No.: 201175875
SIC: 2834 Pharmaceutical Preparations